Elevance Health Inc
ELV: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$897.00 | Nrmrfw | Pfwwmdsj |
Elevance Health Earnings: 2023 and 2024 Outlook Looks Solid Despite Emerging Headwinds
Narrow-moat Elevance Health delivered solid near-term guidance, despite emerging headwinds in its government businesses. At first glance we plan to maintain our $520 fair value estimate or slightly above recent prices.